West Pharmaceutical Services Inc
NYSE:WST
West Pharmaceutical Services Inc
Cash from Investing Activities
West Pharmaceutical Services Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Investing Activities
-$377.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-11%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Investing Activities
-$131.7m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is West Pharmaceutical Services Inc's Cash from Investing Activities?
Cash from Investing Activities
-377.2m
USD
Based on the financial report for Mar 31, 2024, West Pharmaceutical Services Inc's Cash from Investing Activities amounts to -377.2m USD.
What is West Pharmaceutical Services Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-11%
Over the last year, the Cash from Investing Activities growth was -25%. The average annual Cash from Investing Activities growth rates for West Pharmaceutical Services Inc have been -23% over the past three years , -30% over the past five years , and -11% over the past ten years .